ES368325A1 - Un procedimiento para la preparacion de un compuesto de ce-falosporina. - Google Patents

Un procedimiento para la preparacion de un compuesto de ce-falosporina.

Info

Publication number
ES368325A1
ES368325A1 ES368325A ES368325A ES368325A1 ES 368325 A1 ES368325 A1 ES 368325A1 ES 368325 A ES368325 A ES 368325A ES 368325 A ES368325 A ES 368325A ES 368325 A1 ES368325 A1 ES 368325A1
Authority
ES
Spain
Prior art keywords
methyl group
thioltherified
cephalosporius
acylamidoceph
thioetherified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES368325A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES368325A1 publication Critical patent/ES368325A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
ES368325A 1968-06-14 1969-06-13 Un procedimiento para la preparacion de un compuesto de ce-falosporina. Expired ES368325A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2852768 1968-06-14

Publications (1)

Publication Number Publication Date
ES368325A1 true ES368325A1 (es) 1971-06-16

Family

ID=10277050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES368325A Expired ES368325A1 (es) 1968-06-14 1969-06-13 Un procedimiento para la preparacion de un compuesto de ce-falosporina.

Country Status (7)

Country Link
US (1) US3668203A (es)
AT (2) AT301751B (es)
BR (1) BR6909752D0 (es)
CA (1) CA992069A (es)
ES (1) ES368325A1 (es)
GB (1) GB1277415A (es)
ZA (1) ZA694200B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948559B1 (es) * 1970-11-10 1974-12-21
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
US3917588A (en) * 1972-11-28 1975-11-04 Lilly Co Eli {60 -Aminoacyl cephalosporin ethers
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US4091215A (en) * 1974-06-05 1978-05-23 Bristol-Myers Company 7-D-α-Amino-.alpha.-(p-acetoxyphenyl)acetamido-3-methyl-3-cephem-4-carboxylic acid
US4144391A (en) * 1977-03-07 1979-03-13 Eli Lilly And Company Cephalosporin displacement reaction
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130098C (es) * 1963-07-15

Also Published As

Publication number Publication date
CA992069A (en) 1976-06-29
ZA694200B (en) 1971-01-27
AT301751B (de) 1972-09-25
BR6909752D0 (pt) 1973-02-08
US3668203A (en) 1972-06-06
GB1277415A (en) 1972-06-14
AT312165B (de) 1973-12-27

Similar Documents

Publication Publication Date Title
MY8100035A (en) Aryloxyalkanolamine derivatives,their preparation and use in pharmaceutical compositions
PH12097A (en) Pharmaceutically active pepiide and composition thereof
PH10519A (en) 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof
NZ173837A (en) Cephalosporins with a substituted hetero cyclic-thiomethyl side-chain in the 3-position and pharmaceutical compositions
ES368325A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
CA953714A (en) N(6)-aralkyl-adenosine derivatives and process for the preparation thereof
FR2282903A1 (fr) Esters triacyles en positions 9,3'',4'' de l'antibiotique sf-837 m1 et procede de preparation y associe
PH11400A (en) Naphthyridine derivatives and pharmaceutical composition thereof
PH10643A (en) Benzylpyrimidine derivatives and pharmaceutical compositions thereof
AU6413674A (en) Improvements in or relating to injectable therapeutic formulations
PH11219A (en) N-substituted-dihydroxyphenethylamine derivatives and pharmaceutical composition thereof
AU1406570A (en) (1,2,3,4-tetrahydro-6-quinolyl)-carboxylic acids and derivatives thereof
GB1408339A (en) 5,6,7,7alpha-tetrahydro-1h-pyrrolo 1,2-c imidazole-5- carboxylic acids and derivatives thereof
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
AU3279771A (en) New cycloalkano-quinolone derivatives and the preparation thereof
CA742211A (en) 7.alpha.-METHYL ESTRONE AND DERIVATIVES
CA842841A (en) 6-diloweralkylamino-fluoran derivatives and their preparation and use
AU429842B2 (en) New pharmaceutically active 2, 3 benzoazine derivatives
AU290011B2 (en) 5-methoxy-des-a 5,7,9-estratriene derivatives and their preparation
CA784686A (en) Napthalene derivatives in pharmaceutical compositions
CA779303A (en) Pharmaceutically active piperidine derivatives and their preparation
AU435106B2 (en) Novel 1, 5 benzothiazepine derivatives and preparation thereof
AU6096569A (en) 2h 4, 9 ethanobenzisoindolones and derivatives thereof as pharmaceutical agents
AU4368968A (en) New pharmaceutically active 2, 3 benzoazine derivatives
CA819119A (en) 17a-(3'-furyl)-estrogens and process for the preparation thereof